Production (Stage)
BioCryst Pharmaceuticals, Inc.
BCRX
$10.59
$0.201.93%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | -8.03% | -2.78% | 21.32% | -19.17% | -13.48% |
| Total Receivables | 18.12% | 9.13% | 5.38% | 13.49% | 6.38% |
| Inventory | -15.01% | 6.94% | 69.93% | -85.06% | 3.83% |
| Prepaid Expenses | 4.18% | -15.53% | -0.88% | -10.64% | -5.94% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 38.57% | -74.17% | -54.71% | -0.17% | -0.33% |
| Total Current Assets | -2.84% | -1.21% | 17.52% | -18.71% | -9.85% |
|
|
|||||
| Total Current Assets | -2.84% | -1.21% | 17.52% | -18.71% | -9.85% |
| Net Property, Plant & Equipment | -1.06% | 0.78% | -1.11% | -4.16% | -0.96% |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 5.66% | 13.05% | 1.12% | 31,284.81% | -1.25% |
| Total Assets | -2.12% | -0.17% | 3.99% | 0.97% | -9.49% |
|
|
|||||
| Total Accounts Payable | -13.70% | -13.63% | 73.16% | -34.63% | -43.00% |
| Total Accrued Expenses | -18.23% | 8.73% | 16.29% | 13.06% | -22.97% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 4.86% | -1.23% | 13.28% | 10.15% | 9.72% |
| Total Finance Division Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Current Liabilities | -12.80% | 4.44% | 18.98% | 7.63% | -20.05% |
|
|
|||||
| Total Current Liabilities | -12.80% | 4.44% | 18.98% | 7.63% | -20.05% |
| Long-Term Debt | -1.75% | -0.02% | -1.53% | -0.56% | 0.22% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 0.45% | -0.93% | -3.22% | -5.61% | -1.18% |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | -3.56% | 0.68% | 1.24% | 0.42% | -2.92% |
|
|
|||||
| Common Stock & APIC | 1.84% | 1.63% | 1.54% | 1.08% | 1.25% |
| Retained Earnings | 0.00% | -1.54% | -0.81% | -0.74% | -2.10% |
| Treasury Stock & Other | 22.91% | -59.83% | 311.67% | -27.76% | -42.33% |
| Total Common Equity | 5.04% | -1.57% | 1.48% | 0.12% | -4.53% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 5.04% | -1.57% | 1.48% | 0.12% | -4.53% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 5.04% | -1.57% | 1.48% | 0.12% | -4.53% |
|
|
|||||